Recent Updates in Both the Diagnosis and Treatment Options that Impact the Clinical Treatment of Pulmonary Arterial Hypertension
Keyword(s):
The evaluation and management of pulmonary arterial hypertension (PAH) is a rapidly evolving area of subspecialty medicine requiring regular clinical updates. Most notably are changes in the World Health Organization diagnostic scheme whereby the clinician categorizes the correct type of pulmonary hypertension in order direct the most specific evaluation and treatment plan. In addition, there have been several changes in both the FDA-approved pharmaceutical formulations and new agents for the treatment of PAH. This review will provide an update in these areas and more importantly, guidance to the clinician on the most appropriate utilization of these new treatment options.
2019 ◽
Vol 9
(3)
◽
pp. 204589401985647
◽
2019 ◽
Vol 9
(3)
◽
pp. 204589401987715
◽
2009 ◽
Vol 84
(7)
◽
pp. 586-592
◽
2015 ◽
Vol 74
(Suppl 2)
◽
pp. 1131.1-1131
2005 ◽
Vol 128
(4)
◽
pp. 219S
◽
2014 ◽
Vol 13
(2)
◽
pp. 68-75
◽
2021 ◽
Vol 40
(4)
◽
pp. S107